What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

Kaiku Health has taken its first steps to predict treatment response of cancer patients for immune checkpoint inhibitor therapies with machine learning

Kaiku Health has taken its first steps to tackle the big issue related to the challenge of identifying which patients are likely to benefit from immune checkpoint inhibitor (ICI) therapies. The unfortunate fact is that not all eligible patients respond to these therapies at all, and for some of those who have a response, it...

Read the article

Kaiku Health to present research at ESMO Immuno-Oncology Congress 2020

Kaiku Health, together with Oulu University Hospital, will present research at the ESMO Immuno-Oncology Congress 2020, which takes place as a virtual conference this year. The research investigates the use of Machine Learning to predict the objective response rate in immune checkpoint inhibitor treated patients when patient-reported and clinical data data are used as input...

Read the article

Predicting patient-reported symptoms for cancer patients undergoing immune checkpoint inhibitor (ICI) therapies using different measurement system than in prediction model training

Kaiku has continued its work among building machine learning (ML) based prediction models for immunotherapy-related symptom development. A year ago results from the first study were presented in the ESMO IO congress 2019 where it was showcased that ML based modeling of ePRO data on ICI treated cancer patients is feasible in predicting the onset...

Read the article

Kaiku Health receives Digi-HTA recommendation

Kaiku Health, the developer of digital health intervention platform in oncology, has received the Digi-HTA recommendation of use. The Digi-HTA is a criteria tool for assessing digital healthcare services’ (eg. mobile apps, AI solutions, and robotics) suitability for use in healthcare. The recommendation states that:  “The Kaiku Health service is suitable for monitoring the well-being...

Read the article

Increasing the understanding behind treatment response and immune-related adverse events in cancer patients treated with immune checkpoint inhibitor therapies

Increasing the understanding behind treatment response and immune-related adverse events in cancer patients treated with immune checkpoint inhibitor therapies Kaiku Health and Oulu University Hospital (OYS) aim to increase the understanding behind treatment benefit and onset of complex immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapies. The findings from this study conducted...

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
ellen.nurmi@kaikuhealth.com
+358 445512744

Contact

Get in touch with us

Interested in learning more about Kaiku Health? Send us a note